[1] Cui X, Chen L, Ren Y, et al. Genetic modification of mesenchymal stem cells in spinal cord injury repair strategies. Biosci Trends. 2013;7(5):202-208.
[2] Aloe L, Bianchi P, De Bellis A, et al. Intranasal nerve growth factor bypasses the blood-brain barrier and affects spinal cord neurons in spinal cord injury. Neural Regen Res. 2014;9(10): 1025-1030.
[3] Zhang H, Wu F, Kong X, et al. Nerve growth factor improves functional recovery by inhibiting endoplasmic reticulum stress-induced neuronal apoptosis in rats with spinal cord injury. J Transl Med. 2014;12:130.
[4] Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228.
[5] 徐帆,陈建敏,张晓.脊髓损伤动物模型的制备及神经功能评价[J]. 创伤外科杂志,2007,9(1):91-93.
[6] Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol. 1996; 139(2):244-256.
[7] 彭忠勇,陈志斌,修波,等.嗅鞘细胞移植联合督脉电针对脊髓损伤大鼠脊髓诱发电位的影响[J].中国组织工程研究与临床康复, 2009,13(23):4426-4432.
[8] Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci. 2006;7(8):628-643.
[9] Ting LH, Chiel HJ, Trumbower RD, et al. Neuromechanical Principles Underlying Movement Modularity and Their Implications for Rehabilitation. Neuron. 2015;86(1):38-54.
[10] Tanhoffer RA, Tanhoffer AI, Raymond J, et al. Energy expenditure in individuals with spinal cord injury quantified by doubly labeled water and a multi-sensor armband. J Phys Act Health. 2015;12(2):163-170.
[11] Cardenas DD, Emir B, Parsons B.Examining the Time to Therapeutic Effect of Pregabalin in Spinal Cord Injury Patients With Neuropathic Pain.Clin Ther. 2015. [Epub ahead of print]
[12] Nicaise C, Mitrecic D, Falnikar A, et al. Transplantation of stem cell-derived astrocytes for the treatment of amyotrophic lateral sclerosis and spinal cord injury. World J Stem Cells. 2015; 7(2):380-398.
[13] Watanabe S, Uchida K, Nakajima H, et al. Early Transplantation of Mesenchymal Stem Cells after Spinal Cord Injury Relieves Pain Hypersensitivity Through Suppression of Pain-Related Signaling Cascades and Reduced Inflammatory Cell Recruitment.Stem Cells. 2015 Mar 24. doi: 10.1002/stem.2006. [Epub ahead of print]
[14] Garbossa D, Boido M, Fontanella M, et al. Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells. Neurosurg Rev. 2012;35(3):293-311.
[15] Mothe AJ, Tator CH. Advances in stem cell therapy for spinal cord injury. J Clin Invest. 2012;122(11):3824-3834.
[16] Tsuji O, Miura K, Okada Y, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A. 2010;107(28): 12704-12709.
[17] Wang D, Liang J, Zhang J, et al. Mild hypothermia combined with a scaffold of NgR-silenced neural stem cells/Schwann cells to treat spinal cord injury. Neural Regen Res. 2014;9(24): 2189-2196.
[18] Minteer DM, Marra KG, Rubin JP. Adipose Stem Cells: Biology, Safety, Regulation, and Regenerative Potential. Clin Plast Surg. 2015;42(2):169-179.
[19] Kapur SK, Dos-Anjos Vilaboa S, Llull R, et al. Adipose Tissue and Stem/Progenitor Cells: Discovery and Development. Clin Plast Surg. 2015;42(2):155-167.
[20] Kingham PJ, Reid AJ, Wiberg M. Adipose-Derived Stem Cells for Nerve Repair: Hype or Reality. Cells Tissues Organs. 2015 Mar 21. [Epub ahead of print]
[21] Azari MF, Mathias L, Ozturk E, et al. Mesenchymal stem cells for treatment of CNS injury. Curr Neuropharmacol. 2010;8(4): 316-323.
[22] Mufti RE, Sarker K, Jin Y, et al. Thrombin enhances NGF-mediated neurite extension via increased and sustained activation of p44/42 MAPK and p38 MAPK. PLoS One. 2014; 9(7):e103530.
[23] Lin CL, Heron P, Hamann SR, et al. Functional distinction between NGF-mediated plasticity and regeneration of nociceptive axons within the spinal cord. Neuroscience. 2014;272:76-87.
[24] Grill RJ, Blesch A, Tuszynski MH. Robust growth of chronically injured spinal cord axons induced by grafts of genetically modified NGF-secreting cells. Exp Neurol. 1997; 148(2):444-452.
[25] Shi B, Ding J, Liu Y, et al. ERK1/2 pathway-mediated differentiation of IGF-1-transfected spinal cord-derived neural stem cells into oligodendrocytes. PLoS One. 2014;9(8): e106038.
[26] Wang LJ, Zhang RP, Li JD. Transplantation of neurotrophin-3-expressing bone mesenchymal stem cells improves recovery in a rat model of spinal cord injury. Acta Neurochir (Wien). 2014;156(7):1409-1418.
[27] Zhang YJ, Zhang W, Lin CG, et al. Neurotrophin-3 gene modified mesenchymal stem cells promote remyelination and functional recovery in the demyelinated spinal cord of rats. J Neurol Sci. 2012;313(1-2):64-74.
[28] Kumagai G, Tsoulfas P, Toh S, et al. Genetically modified mesenchymal stem cells (MSCs) promote axonal regeneration and prevent hypersensitivity after spinal cord injury. Exp Neurol. 2013;248:369-380.
[29] Sasaki M, Radtke C, Tan AM, et al. BDNF-hypersecreting human mesenchymal stem cells promote functional recovery, axonal sprouting, and protection of corticospinal neurons after spinal cord injury. J Neurosci. 2009;29(47):14932-14941.
[30] Schor NF. The p75 neurotrophin receptor in human development and disease. Prog Neurobiol. 2005;77(3): 201-214.
[31] Ginty DD, Segal RA. Retrograde neurotrophin signaling: Trk-ing along the axon. Curr Opin Neurobiol. 2002;12(3): 268-274. |